AR and breast carcinoma: ZFHX3 loss promotes ESR1-mediated cell proliferation in ESR1-positive breast cancer cells by upregulating breast cancer stem cells and MYC transcription, and similar findings have been reported in androgen receptor-positive prostate cancer [50, 53].